SCHEDULE 13G/A: BlackRock Amends MicroVision Stake to 5.8%

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.8% beneficial ownership stake in MicroVision, Inc. common stock.

Summary

• BlackRock, Inc. filed an Amendment No. 4 to its Schedule 13G for MicroVision, Inc. common stock.
• As of the event date of September 30, 2025, BlackRock, Inc. beneficially owns an aggregate of 17,358,107 shares of MicroVision, Inc. common stock.
• This represents 5.8% of the class of MicroVision, Inc. common stock.
• BlackRock, Inc. holds sole voting power over 17,052,052 shares and sole dispositive power over 17,358,107 shares.
• No shared voting or dispositive power is reported.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of MicroVision, Inc.
• BlackRock, Inc. operates from 50 Hudson Yards, New York, NY 10001.
• Several BlackRock subsidiaries are identified as relevant, with BlackRock Investment Management, LLC noted as beneficially owning 5% or greater of the outstanding shares.

Sentiment

Score: 6

Explanation: BlackRock's continued significant beneficial ownership of 5.8% in MicroVision, Inc. common stock indicates ongoing institutional interest, which is generally viewed as a neutral to slightly positive signal for the issuer.

Positives

• BlackRock, Inc.'s continued beneficial ownership of a significant stake (5.8%) in MicroVision, Inc. indicates ongoing institutional interest and confidence in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding MicroVision, Inc.'s future performance or strategic direction.

Management Comments

• BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing represents a routine disclosure of institutional ownership, common among large asset managers like BlackRock. It indicates continued institutional interest in MicroVision, Inc. within the broader market.

Stakeholder Impact

• Shareholders of MicroVision, Inc. may view BlackRock's continued significant stake as a sign of ongoing institutional confidence in the company.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure by BlackRock, Inc. updating its beneficial ownership in MicroVision, Inc. to 5.8%. It does not provide new financial performance data, strategic updates, or operational insights for MicroVision. While BlackRock's continued significant stake suggests ongoing institutional interest, the filing itself does not present information that would warrant a change from a 'hold' position for a seasoned investor, as it primarily confirms an existing institutional presence rather than signaling new catalysts or concerns.

Keywords

MicroVision, MVIS, BlackRock, Institutional Ownership, Schedule 13G, Common Stock, Beneficial Ownership, Investment